Orna Therapeutics Funding: $100M Raised, Series A (2021)
Orna Therapeutics is based in Cambridge. It has raised $100M in total funding. Latest round: Series A. Backed by MPM Capital, Taiho Ventures, F2 Ventures.
Orna Therapeutics funding overview
Orna Therapeutics is based in Cambridge. Orna Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in February 2021. The round record for Orna Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include MPM Capital, Taiho Ventures, F2 Ventures, Kite, a Gilead Company, Bristol Myers Squibb, Astellas Venture Management and 2 others. 8 distinct backers are named across the disclosed rounds.
Orna Therapeutics at a glance
Total raised
$100M
Latest round
Series A
Latest round date
February 2021
Headquarters
Cambridge
Notable investors
MPM Capital, Taiho Ventures, F2 Ventures, Kite, a Gilead Company, Bristol Myers Squibb, Astellas Venture Management, Novartis Institutes for Biomedical Research, PAGS Group
Frequently asked about Orna Therapeutics funding
How much has Orna Therapeutics raised?
Orna Therapeutics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Orna Therapeutics?
MPM Capital, Taiho Ventures, F2 Ventures, Kite, a Gilead Company, Bristol Myers Squibb, Astellas Venture Management are named among the investors backing Orna Therapeutics.
What was the latest Orna Therapeutics funding round?
The most recent disclosed round is a Series A, announced in February 2021.
Where is Orna Therapeutics based?
Orna Therapeutics is based in Cambridge.
When did Orna Therapeutics last raise?
The last disclosed Orna Therapeutics round closed in February 2021 at Series A.
Every Orna Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
